More importantly, the expression of these receptors in brain is altered in neurodegenerative diseases such as Parkinson’s, Alzheimer’s and in prefrontal cortex in schizophrenia [55], disorders in which MeCP2 expression has been also observed to be dysregulated [16]. This evidence concerns the gene MECP2 and neurodegenerative disease.